Affordable Access

Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.

Authors
Type
Published Article
Journal
Clinical Therapeutics
0149-2918
Publisher
Elsevier
Publication Date
Volume
23
Issue
8
Pages
1272–1280
Identifiers
PMID: 11558863
Source
Medline
License
Unknown

Abstract

In this population, olopatadine was significantly more effective than azelastine in the management of itching associated with allergic conjunctivitis in the CAC model.

Statistics

Seen <100 times